Sybille L. Sauter

FIV Vector Systems

S. Sauter, M. Gasmi, Sybille L. Sauter, 2001, Somatic cell and molecular genetics.

Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors

B. Davidson, J. Chiorini, T. Dubensky, 2000, Neuroreport.

Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect.

B. Davidson, T. Dubensky, S. Keshavjee, 1999, The Journal of clinical investigation.

Binding of nonspecific cross-reacting antigen, a granulocyte membrane glycoprotein, to Escherichia coli expressing type 1 fimbriae

S. Rutherfurd, C. Wagener, J. Shively, 1991, Infection and immunity.

Feline immunodeficiency virus vectors. Gene transfer to mouse retina following intravitreal injection

B. Davidson, S. Sauter, T. Derksen, 2002, The journal of gene medicine.

VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum.

P. Sheridan, T. Dubensky, D. Jolly, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Expression of carcinoembryonic antigen and its predicted immunoglobulin-like domains in HeLa cells for epitope analysis.

L. Hefta, S. Oikawa, H. Nakazato, 1992, Cancer research.

In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.

I. Martins, B. Davidson, P. McCray, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer.

S. Chang, P. Sheridan, T. Dubensky, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.